Intravenous administration of 1 × 107 CEA‐CAR‐T cells in combination with 1500 U/mouse IL-12 showed stronger anti-tumor function compared with CEA‐CAR‐T cell administration in mice model. The gene discussed is CEACAM5; the disease is neoplasm.